Press Releases

Phastar Scoops Multiple Finalist Positions in 2025 SCRIP Awards

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as finalists in two categories at the prestigious 2025 SCRIP Awards.

Advarra’s site-sponsor consortium publishes industry report and master mutual CDA template to streamline feasibility and reduce study startup timelines

Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the Site-Sponsor Consortium’s first industry deliverable designed to streamline a common bottleneck in clinical trials: the Confidential Disclosure Agreement (CDA).

Industry Veterans Establish Ripston, Specialized Clinical Trial Marketing Agency

Ripston helps B2B clinical trial startups build strategic foundations, achieve product-market fit, balance authenticity with AI adoption, and expand to new markets.

Quantabio Advances Newborn Screening and Emerging Applications by Streamlining DNA Extraction from Dried Blood Spot Samples

Quantabio launched the sparQ Lysis Kit, a flexible solution that delivers high-quality, double-stranded genomic DNA from DBS punches in under 50 minutes.

PromoCell enters the GMP field with custom cell culture media services for cell-based therapy and regenerative medicine

PromoCell GmbH has announced its entry into the Good Manufacturing Practice field.

Amorphical Announces Positive Interim Results from Ongoing Clinical Trial in Crohn’s Disease

Novel Nano-Amorphous Mineral-Based Therapy Shows Meaningful Clinical Improvement and Remission in Patients with Moderate-to-Severe Disease

OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA Platform

Symbiosis Expands Sterile Manufacturing Capacity with Fill/Finish Line Qualification 

Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk

ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test

ClearNote Health Receives UKCA markings for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test

Takara Bio Europe Launches Cellartis® MSC EV Wonder™, a Defined, Xeno-Free Medium for High-Yield EV Production

Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder.

MIB Agents Now Accepting Letters of Intent for Annual OutSmarting Osteosarcoma Research Grants

Nonprofit Awards Grants to Projects Focused on Moving Research Forward for Rare Bone Cancer Patients

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Certara on Sept. 22 launched a new capability in its Drug Interaction Database (DIDB) - the pharmaceutical industry’s largest scientist-curated collection of human in vitro and clinical data used to assess drug-drug interactions (DDIs) and safety - that allows researchers to rapidly identify medications that could impact a drug’s effects when taken together, allowing for safer and more intentional drug development.

Huateng Pharma Provides Key Intermediate for Phase 3 Drug Candidate Aficamten

Hunan Huateng Pharmaceutical Co., Ltd. provides 1-Methyl-1H-Pyrazole-4-Carboxylic Acid (CAS 5952-92-1), a high-purity intermediate used in the synthesis of Aficamten (CK-274), an investigational cardiac myosin inhibitor currently in Phase 3 trials for hypertrophic cardiomyopathy.

LabConnect Partners with The Bracken Group to Expand Radiopharmaceutical Support Services

LabConnect has announced a strategic collaboration with The Bracken Group to expand its radiopharmaceutical support services, addressing fast-growing demand in the field. The partnership combines LabConnect’s global operational expertise with Bracken’s scientific and regulatory leadership, strengthening support for biotech and pharmaceutical companies developing targeted therapies and diagnostics. Together, the organizations aim to enhance capabilities in logistics, sample processing, and scientific oversight for complex radiopharmaceutical trials.

Carolina Molecular Inc. and Astoriom to Collaborate on Integrated Molecular Testing and Biospecimen Storage Services

Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech Partners

Arkivum announces new partnership with unified trial management platform provider PHARMASEAL

Arkivum is delighted to announce a new partnership with PHARMASEAL, the provider of the Engility® Trial Management Platform, consisting of a Clinical Trial Management System (CTMS) and Electronic Trial Master File (eTMF).

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

electronRx to Launch pDx App for Remote Chronic Respiratory Disease Management

● Technology detects digital biomarkers to help monitor lung function and optimise therapeutic outcomes for patients ● electronRx to showcase pDx at HLTH 2025 (19–22 Oct, Las Vegas)

LabConnect and OmniScience to Deliver First Agentic AI Solution for Real-Time Clinical Trial Lab Insights

LabConnect and OmniScience have a strategic collaboration to launch the first AI-powered solution for real-time clinical trial lab data insights, streamlining fragmented lab datasets and automating oversight for trial sponsors. Their collaboration centers on OmniScience’s Vivo platform, which provides instant analysis and actionable intelligence from complex laboratory data to accelerate trial timelines and improve outcomes. Both companies aim to revolutionize clinical development by integrating LabConnect’s lab expertise with OmniScience’s AI-native approach, boosting efficiency and supporting faster delivery of life-changing therapies.